allodynia glp 1 Understanding Allodynia: A Side Effect of GLP-1 Medications Pharmacovigilance analysis of neurological adverse

The contents of this site contain general information and may not reflect current legal developments or address your situation

Besides this, increasing awareness of the advantages of these drugs through marketing efforts and direct-to-consumer advertising, particularly on social media, and a favorable regulatory landscape are enabling approvals and boosting demand in the market

If a pediatric patient has not lost at least 3% of baseline BMI, increase the dosage to phentermine 11.25 mg/topiramate 69 mg) orally once daily for 14 days

This underlying diversity in techniques, patient demographics, and data collecting methods, thereby impacting the consistency of findings and the generalizability of our results

However, current evidence does not strongly justify the cessation of GLP-1 RAs based on suicidality concerns